The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJz Capital Regulatory News (JZCP)

Share Price Information for Jz Capital (JZCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 215.00
Bid: 190.00
Ask: 240.00
Change: -9.00 (-4.19%)
Spread: 50.00 (26.316%)
Open: 215.00
High: 206.00
Low: 206.00
Prev. Close: 215.00
JZCP Live PriceLast checked at -
JZ Capital Partners is an Investment Trust

The strategy is to realise investments, pay down debt and reduce commitments to new investments. In addition, the company will return capital to Shareholders while meeting the capital requirements of the portfolio in order to achieve NAV growth.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

26 Jun 2018 15:33

JZ Capital Partners Ltd - Result of AGM

JZ Capital Partners Ltd - Result of AGM

PR Newswire

London, June 26

JZ CAPITAL PARTNERS LIMITED (the "Company" or “JZCP”)(a closed-end collective investment scheme incorporated as a non-cellular company with limited liability under the laws of Guernsey with registered number 48761)

LEI: 549300TZCK08Q16HHU44

RESULTS OF ANNUAL GENERAL MEETING

At the Annual General Meeting (the “AGM”) of the Company held on 26 June 2018, all Resolutions as set out in the AGM Notice dated 21 May 2018 (the “Notice”) and sent to shareholders of the Company were duly passed.

Details of the final voting position in respect of the valid proxies received by the Company should be read alongside the Notice and are noted below:

Ordinary ResolutionForAgainstAbstain
145,187,6221,682,2990
245,187,6221,682,2990
345,187,6221,682,2990
445,187,6221,682,2990
5(1)68,9611,2360
6(1)68,1592,0370
7(1)68,9611,2360
8(1)68,9611,2360
945,187,6221,682,2990
Extraordinary Resolution
1045,187,6221,682,2990

Note - A vote withheld is not a vote in law and has not been counted in the votes for and against a resolution. 

(1) The proxy voting results in respect of Ordinary Resolutions 5 through to 8 have been counted in accordance with Article 14(17) of the Articles of Incorporation of the Company.

In relation to Resolutions 9 and 10 above, the Company has been given authority to make acquisitions of its own shares in the capital of the Company subject to certain limitations as set out in the Resolutions. Any such acquisitions of own shares that may be undertaken by the Company pursuant to those Resolutions are intended to be effected on the basis of and within the same defined parameters that applied for the previous period for which such authorities were granted, including the "percentage of NAV parameter" as defined and as set out fully in the announcement made by the Company on 28 March 2018. Shareholders are again reminded that although the Company retains the power to do so, it is not obliged to carry out acquisitions of its own shares, and as such, the Company may undertake such acquisitions when it so chooses including as and when opportunities in the market permit and as its cash resources allow at the time.

The Company has instructed J.P. Morgan Securities plc to act as its broker in respect of any on-market acquisitions of its own shares that may be undertaken by the Company.

At the same AGM noted above, the following Special Business by Ordinary Resolution was also passed as detailed below:

11. SPECIAL BUSINESS BY ORDINARY RESOLUTION:To authorise the Directors in accordance with Article 4(8) of the Articles of Incorporation of the Company (the “Articles”) to: (a) allot equity securities (as defined in the Articles) of the Company for cash; and (b) sell ordinary shares (as defined in the Articles) held by the Company as treasury shares for cash, as if Article 4(8) of the Articles did not apply to any such allotment or sale, provided that this power shall be limited to the allotment of equity securities for cash and the sale of treasury shares up to an aggregate amount of 8,371,883 ordinary shares, such authority to expire at the conclusion of the general meeting of the Company to be held in 2019 or on 30 June 2019, whichever is the earlier, save that the Company may before such expiry make any offer or agreement that would or might require equity securities to be allotted, or treasury shares to be sold, after such expiry and the Directors may allot equity securities, or sell treasury shares in pursuance of any such offer or agreement as if the power conferred hereby had not expired.

Special Business by Ordinary ResolutionForAgainstAbstain
1143,443,7233,426,1980

Note - A vote withheld is not a vote in law and has not been counted in the votes for and against a resolution. 

Enquiries: Company website: www.jzcp.com Franczeska Hanford Northern Trust International Fund Administration Services (Guernsey) Limited Tel: +44 (0) 1481 745001 Email: FK26@ntrs.com

Date   Source Headline
17th May 20127:00 amRNSNet Asset Value(s)
27th Apr 20129:07 amRNSNet Asset Value(s)
17th Apr 20124:04 pmRNSNotice of Results - Replacement
13th Apr 20128:57 amRNSNotice of Results
24th Feb 201210:05 amRNSNew Accounting Ref Date
23rd Feb 20129:23 amRNSNet Asset Value(s)
25th Jan 20125:02 pmRNSHolding(s) in Company
25th Jan 20122:17 pmRNSTotal Voting Rights
20th Jan 20124:49 pmRNSHolding(s) in Company
19th Jan 20125:31 pmRNSDirector/PDMR Shareholding
19th Jan 20125:30 pmRNSDirector/PDMR Shareholding
19th Jan 20125:29 pmRNSDirector/PDMR Shareholding
19th Jan 20125:27 pmRNSDirector/PDMR Shareholding
17th Jan 20129:22 amRNSNet Asset Value(s)
16th Jan 201211:46 amRNSHolding(s) in Company
10th Jan 20123:33 pmRNSHolding(s) in Company
29th Dec 201110:03 amRNSHolding(s) in Company
28th Dec 20119:34 amRNSNet Asset Value(s)
22nd Dec 20115:23 pmRNSDirector/PDMR Shareholding
22nd Dec 20119:43 amRNSHolding(s) in Company
20th Dec 20117:00 amRNSJZCP Q3 Interim Management Statement
14th Dec 201111:23 amRNSHolding(s) in Company
6th Dec 20111:58 pmRNSHolding(s) in Company
2nd Dec 20117:00 amRNSCompletes Sale of Wound Care Holdings LLC
1st Dec 20119:17 amRNSConversion of Securities
23rd Nov 20114:17 pmRNSNet Asset Value(s)
31st Oct 20119:52 amRNSNet Asset Value(s)
25th Oct 20112:55 pmRNSDisposal
20th Oct 20114:28 pmRNSHolding(s) in Company
19th Oct 20112:02 pmRNSDividend Declaration
18th Oct 20113:58 pmRNSNet Asset Value(s)
18th Oct 20117:00 amRNSInterim Results 2011
10th Oct 201110:48 amRNSHolding(s) in Company
5th Oct 20119:25 amRNSHolding(s) in Company
27th Sep 20119:28 amRNSHolding(s) in Company
16th Sep 20118:58 amRNSNotice of Interim Results
25th Aug 20117:00 amRNSConversion of Shares
12th Aug 20118:18 amRNSNet Asset Value(s)
18th Jul 20117:00 amRNSAcquisition and realisation of Investments
13th Jul 20118:30 amRNSNet Asset Value(s)
28th Jun 20115:01 pmRNSResult of AGM
21st Jun 201112:44 pmRNSNet Asset Value(s)
21st Jun 20117:00 amRNSInterim Management Statement
26th May 20118:10 amRNSNet Asset Value(s)
24th May 20116:01 pmRNSNotice of AGM
12th May 20118:53 amRNSNet Asset Value(s)
9th May 20113:36 pmRNSDividend Declaration
9th May 20117:00 amRNSAnnual Results for Period Ending 28 February 2011
3rd May 20112:26 pmRNSNotice of Results
13th Apr 20118:33 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.